Relationship between Serum Level of Lymphatic Vessel Endothelial Hyaluronan Receptor-1 and Prognosis in Patients with Lung Cancer. - Wikidata - wikimedia - TriplyDB

Relationship between Serum Level of Lymphatic Vessel Endothelial Hyaluronan Receptor-1 and Prognosis in Patients with Lung Cancer.

Relationship between Serum Level of Lymphatic Vessel Endothelial Hyaluronan Receptor-1 and Prognosis in Patients with Lung Cancer.

http://www.wikidata.org/entity/Q37657329

about

Exosomal amyloid A and lymphatic vessel endothelial hyaluronic acid receptor-1 proteins are associated with disease activity in rheumatoid arthritis.HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.The optimum marker for the detection of lymphatic vessels.Lymphatic vessel density as a prognostic indicator in Asian NSCLC patients: a meta-analysis

P2860

Q33750084-0348F1BF-1D80-4519-B1A0-BDA2F7AEF698 Q35869764-EFEE2E13-5172-4ACB-8B72-74A61BC4AFEC Q41542533-085D13F0-645D-493F-8474-7704A237E895 Q58798799-80111622-F979-437E-B37B-0EC5A5AB80EF

P2860

Relationship between Serum Level of Lymphatic Vessel Endothelial Hyaluronan Receptor-1 and Prognosis in Patients with Lung Cancer.

http://www.wikidata.org/entity/Q37657329

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Relationship between Serum Lev ...... in Patients with Lung Cancer.

@en

Relationship between Serum Lev ...... in Patients with Lung Cancer.

@nl

type

label

Relationship between Serum Lev ...... in Patients with Lung Cancer.

@en

Relationship between Serum Lev ...... in Patients with Lung Cancer.

@nl

prefLabel

Relationship between Serum Lev ...... in Patients with Lung Cancer.

@en

Relationship between Serum Lev ...... in Patients with Lung Cancer.

@nl

P1433

Q37657329-37F64E39-3F50-49D1-B16D-3241FA04F5AB

P1476

Q37657329-631E3EEC-A543-4DFE-8226-FA83C12162A5

P2093

Q37657329-1442633C-EB70-4186-8F6E-98D4A5207D56

Q37657329-493BAF14-C3D8-4214-B2BD-2BF435084799

Q37657329-49AD6D3B-DCAF-40C2-B12D-A4E4BD12C1D1

Q37657329-62FF5000-FFA9-447A-9C2F-4C8A2D8E2EC4

Q37657329-6528F60E-C4D0-431D-A649-A9A08C3D7A32

Q37657329-8231A83B-C333-495E-A4E4-221D067C0C95

Q37657329-8293E0F5-8F85-47CD-BF52-884A1C6C53E1

Q37657329-88233F88-0D4C-484D-B8AF-501610363B2A

Q37657329-8D76B278-88EB-4007-9362-F2182265F402

Q37657329-AA8B233B-7835-4432-9363-BC56D30049FD

P2860

Q37657329-09E0C89E-9279-470A-857E-665E64E83E25

Q37657329-0B8E02E1-E470-446C-95AD-02814D066B94

Q37657329-0EAC4E5D-50C5-4B19-BF28-CCB9D2340D19

Q37657329-1049D306-AC97-40E7-85D8-9D8F2886A0EC

Q37657329-205B7EF7-65B9-4AD7-861A-B31EA69E3DE4

Q37657329-29728F29-593B-4B1A-A0D5-DF517D0BFA3B

Q37657329-399715FE-F99B-497E-8302-8D00AE32E7CD

Q37657329-40E56148-EEDB-4230-928F-23D5CE7AD980

Q37657329-4344E0A8-E5C6-42F2-9189-25FA7EB7CEF6

Q37657329-4D3DF1FF-CF73-4E28-B215-6FE6057CD0EB

P304

Q37657329-4FFF5B60-E315-43CA-8703-30283205D8B2

P31

Q37657329-218B0DDD-762F-430F-9A8E-EA655A35ABCD

P356

Q37657329-13F2D61D-654F-4201-B735-6BD73CB43F99

P433

Q37657329-AAA72195-A3D3-4481-A962-5538DD1FD160

P478

Q37657329-E67E2544-89C1-4D0B-8246-46783811FE4F

P577

Q37657329-896E5C86-2234-486E-9361-A8A5D75CA9C8

P5875

Q37657329-740DDF44-52C8-4E88-8153-10E63F779D0D

P698

Q37657329-131A0AB0-041D-4330-BC3D-C81CE2BEA7EA

P921

Q37657329-A15AFD5C-603B-4F11-BB5E-5FC4BBD697E4

P932

Q37657329-D2B035E6-5BF1-40C6-926A-9140E063804A

P356

P1433

Journal of Cancer

P1476

Relationship between Serum Lev ...... in Patients with Lung Cancer.

@en

P2093

Akira Igarashi

http://www.w3.org/2001/XMLSchema#string

Hiroshi Nakano

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Kishi

http://www.w3.org/2001/XMLSchema#string

Isao Kubota

http://www.w3.org/2001/XMLSchema#string

Keiko Nunomiya

http://www.w3.org/2001/XMLSchema#string

Keiko Yamauchi

http://www.w3.org/2001/XMLSchema#string

Kento Sato

http://www.w3.org/2001/XMLSchema#string

Masamichi Sato

http://www.w3.org/2001/XMLSchema#string

Shuichi Abe

http://www.w3.org/2001/XMLSchema#string

Sumito Inoue

http://www.w3.org/2001/XMLSchema#string

P2860

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

Expression of hyaluronan in human tumor progression.

Cancer statistics, 2013

Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium

High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study

Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.

The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA.

Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer

The interaction between LYVE-1 with hyaluronan on the cell surface may play a role in the diversity of adhesion to cancer cells.

P304

242-247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.8486

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261069379

http://www.w3.org/2001/XMLSchema#string

P698

24665348

http://www.w3.org/2001/XMLSchema#string

P921

P932

3963081

http://www.w3.org/2001/XMLSchema#string